The Inquiry Committee has reinstated the pharmacist registrant’s registration which had previously been suspended for an indefinite period on December 19, 2022. Pursuant to Section 32.2(4)(b)(i) of the Health Professions Act, the Inquiry Committee has reached a Consent Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:
- To comply with any and all treatment plans as recommended by their medical providers.
-
To comply with any and all work plans as advised by their medical providers and/or employers.
-
To comply with every term of their Relapse Prevention Agreement (“RPA”).
-
In the event of any interruption to the agreed monitoring schedule set out in the RPA, the registrant will advise the College of the interruption as soon as possible and provide an explanation for the interruption.
-
To not handle or dispense opioid medications for a period of one (1) year after returning to practice;
-
To not work more than forty (40) hours per week for a period of 3-months after returning to work;
-
The registrant will inform the College in writing, via e-mail, of their places of work as a pharmacist and report any changes to the location of their work within 48 hours of such change. A reportable change to the registrant’s place of work contemplates both commencement and termination of work.
- Prior to the commencement of work at any pharmacy, the registrant shall:
- Disclose to the pharmacy manager and/or employer the limits and conditions on their license pursuant to their Consent Agreement;
- Ensure that any pharmacy manager and/or employer with whom the registrant secures work in a pharmacy submits a written statement to the College declaring their awareness of the registrant’s Consent Agreement and the limits and conditions on the registrant’s license to practice pharmacy. This statement must be received within 48 hours of securing work and/or within 48 hours of any change of pharmacy manager at the registrant’s place of work.
The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.
December 19, 2022
(June 19, 2023 - Registration Reinstated)
The Inquiry Committee, pursuant to s. 32.2(4)(b)(ii) of the Health Professions Act, has reached an Agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective December 19, 2022. The Agreement remains in effect until further notice. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.